131 related articles for article (PubMed ID: 26165719)
21. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1.
Kouhkan F; Mobarra N; Soufi-Zomorrod M; Keramati F; Hosseini Rad SM; Fathi-Roudsari M; Tavakoli R; Hajarizadeh A; Ziaei S; Lahmi R; Hanif H; Soleimani M
J Med Genet; 2016 Jan; 53(1):24-33. PubMed ID: 26510428
[TBL] [Abstract][Full Text] [Related]
23. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
24. MiR-224 expression increases radiation sensitivity of glioblastoma cells.
Upraity S; Kazi S; Padul V; Shirsat NV
Biochem Biophys Res Commun; 2014 May; 448(2):225-30. PubMed ID: 24785373
[TBL] [Abstract][Full Text] [Related]
25. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma.
Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW
Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440
[TBL] [Abstract][Full Text] [Related]
26. [Differential expression of Notch1 and Notch2 in astrocytoma and medulloblastoma].
Xu P; Pu PY; Kang CS; Jia ZF; Zhou X; Wang GX
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):450-3. PubMed ID: 19035115
[TBL] [Abstract][Full Text] [Related]
27. Association between microRNA polymorphisms and the risk of inflammatory bowel disease.
Zhu M; Li D; Jin M; Li M
Mol Med Rep; 2016 Jun; 13(6):5297-308. PubMed ID: 27109937
[TBL] [Abstract][Full Text] [Related]
28. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
29. The different role of Notch1 and Notch2 in astrocytic gliomas.
Xu P; Zhang A; Jiang R; Qiu M; Kang C; Jia Z; Wang G; Han L; Fan X; Pu P
PLoS One; 2013; 8(1):e53654. PubMed ID: 23349727
[TBL] [Abstract][Full Text] [Related]
30. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.
Sivasankaran B; Degen M; Ghaffari A; Hegi ME; Hamou MF; Ionescu MC; Zweifel C; Tolnay M; Wasner M; Mergenthaler S; Miserez AR; Kiss R; Lino MM; Merlo A; Chiquet-Ehrismann R; Boulay JL
Cancer Res; 2009 Jan; 69(2):458-65. PubMed ID: 19147558
[TBL] [Abstract][Full Text] [Related]
31. [Association between genetic polymorphisms in pre-miR-146a and pre-miR-196a2 and genetic damage levels among coke oven workers].
Wang T; Deng QF; Zhang X; Li XL; Deng SY; Dai XY; Huang SL; Feng J; Li J; Wu TC; Guo H
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):741-6. PubMed ID: 24246082
[TBL] [Abstract][Full Text] [Related]
32. PKCδ activated by c-MET enhances infiltration of human glioblastoma cells through NOTCH2 signaling.
Hwang E; Yoo KC; Kang SG; Kim RK; Cui YH; Lee HJ; Kim MJ; Lee JS; Kim IG; Suh Y; Lee SJ
Oncotarget; 2016 Jan; 7(4):4890-902. PubMed ID: 26700818
[TBL] [Abstract][Full Text] [Related]
33. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation.
Wang L; Wei Q; Wang LE; Aldape KD; Cao Y; Okcu MF; Hess KR; El-Zein R; Gilbert MR; Woo SY; Prabhu SS; Fuller GN; Bondy ML
J Clin Oncol; 2006 Apr; 24(10):1627-32. PubMed ID: 16575014
[TBL] [Abstract][Full Text] [Related]
34. Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1.
Li Y; He ZC; Zhang XN; Liu Q; Chen C; Zhu Z; Chen Q; Shi Y; Yao XH; Cui YH; Zhang X; Wang Y; Kung HF; Ping YF; Bian XW
Cancer Lett; 2018 Mar; 416():66-74. PubMed ID: 29196129
[TBL] [Abstract][Full Text] [Related]
35. miRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease.
Sung JH; Kim SH; Yang WI; Kim WJ; Moon JY; Kim IJ; Cha DH; Cho SY; Kim JO; Kim KA; Kim OJ; Lim SW; Kim NK
Mol Med Rep; 2016 Sep; 14(3):2328-42. PubMed ID: 27430349
[TBL] [Abstract][Full Text] [Related]
36. Integrated Cox's model for predicting survival time of glioblastoma multiforme.
Ai Z; Li L; Fu R; Lu JM; He JD; Li S
Tumour Biol; 2017 Apr; 39(4):1010428317694574. PubMed ID: 28381184
[TBL] [Abstract][Full Text] [Related]
37. MiR-106a is an independent prognostic marker in patients with glioblastoma.
Zhao S; Yang G; Mu Y; Han D; Shi C; Chen X; Deng Y; Zhang D; Wang L; Liu Y; Hou X; Wang C; Wu J; Liu H; Wang L; Zhang G; Qi J; Fang X; Shi C; Ai J
Neuro Oncol; 2013 Jun; 15(6):707-17. PubMed ID: 23416698
[TBL] [Abstract][Full Text] [Related]
38. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
Chen J; Yang L; Wang X
Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
[TBL] [Abstract][Full Text] [Related]
39. The rs2910164 G>C polymorphism in microRNA-146a is associated with the incidence of malignant melanoma.
Yamashita J; Iwakiri T; Fukushima S; Jinnin M; Miyashita A; Hamasaki T; Makino T; Aoi J; Masuguchi S; Inoue Y; Ihn H
Melanoma Res; 2013 Feb; 23(1):13-20. PubMed ID: 23222547
[TBL] [Abstract][Full Text] [Related]
40. Role of the GNAS1 T393C polymorphism in patients with glioblastoma multiforme.
El Hindy N; Lambertz N; Bachmann HS; Frey UH; Adamzik M; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
J Clin Neurosci; 2011 Nov; 18(11):1495-9. PubMed ID: 21924916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]